THCIntoxicating
Delta-9-tetrahydrocannabinol
FDA-approved
The compound behind the high, and behind much of the medical value. Dronabinol, a THC medicine sold as Marinol and Syndros, is FDA-approved for chemotherapy nausea and AIDS-related appetite loss21. Cannabis is a proven treatment for chronic pain in adults11.
THCANon-intoxicating
Tetrahydrocannabinolic acid
Early / lab research
The raw form of THC in the living plant. It doesn't get you high until heat turns it into THC18 19. Lab studies point to anti-inflammatory and brain-protective effects19 46, and it reduced nausea in animal studies47. THC vs. THCA, explained →
CBDNon-intoxicating
Cannabidiol
FDA-approved
The World Health Organization's expert committee found that "in humans, CBD exhibits no effects indicative of any abuse or dependence potential," and that it is "generally well tolerated with a good safety profile"108. Epidiolex, a CBD medicine, is FDA-approved for severe childhood epilepsies21, and CBD eased anxiety in a public-speaking trial97.
CBGNon-intoxicating
Cannabigerol, the “mother” cannabinoid
Early human trial
The plant uses CBG as the starting molecule for its most abundant cannabinoids, and lab research points to potential uses in neurological and inflammatory bowel conditions112. In a placebo-controlled trial, 20 mg of CBG reduced anxiety and stress and improved verbal memory, with no sign of impairment113.
CBNNot intoxicating at studied doses
Cannabinol
Early, mixed
CBN forms when THC oxidizes129, and it's marketed for sleep. In a randomized trial of 293 people with poor sleep, 20 mg of CBN reduced nighttime awakenings and overall sleep disturbance without next-day fatigue115. In another trial, a single high dose improved how well people with insomnia felt they slept, but not lab-measured time awake129. A 2021 review noted that older research was thin, so these new trials matter114.
THCVNot intoxicating at studied doses
Tetrahydrocannabivarin
Early human trials
In a randomized trial in people with type 2 diabetes, THCV significantly lowered fasting blood sugar and improved insulin-producing cell function compared with placebo116. In healthy volunteers it felt no different from placebo, and it softened some effects of THC, such as the faster heart rate. Most people said THC felt weaker with THCV on board117.